ClinicalTrialsFinder

Refractory Grade 2 Follicular Lymphoma Clinical Trials in Irvine, California

1 recruitingIrvine, California

Showing 1–1 of 1 trials

Recruiting
Phase 2

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3a Follicular Lymphoma+3 more
City of Hope Medical Center41 enrolled2 locationsNCT06453044